171 related articles for article (PubMed ID: 34034600)
1. Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection.
Waldenström J; Kåberg M; Alanko Blomé M; Widell A; Björkman P; Nilsson S; Hammarberg A; Weiland O; Nyström K; Lagging M
Scand J Gastroenterol; 2021 Jul; 56(7):855-861. PubMed ID: 34034600
[TBL] [Abstract][Full Text] [Related]
2. Presence of interferon-λ 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus.
Waldenström J; Hellstrand K; Westin J; Nilsson S; Christensen P; Färkkilä M; Mørch K; Langeland N; Norkrans G; Lagging M
Scand J Gastroenterol; 2021 Jul; 56(7):849-854. PubMed ID: 34078234
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
[TBL] [Abstract][Full Text] [Related]
4. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
[TBL] [Abstract][Full Text] [Related]
5. Associations of ITPA gene polymorphisms with outcomes among chronic hepatitis C patients treated with Peg-interferon/ribavirin: A 5-year follow-up study.
Liu Z; Wang Y; Li H; Wang X; Wang X; Xu X; Ma C; Wang J
Medicine (Baltimore); 2023 Oct; 102(43):e35508. PubMed ID: 37904484
[TBL] [Abstract][Full Text] [Related]
6. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S
J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.
Grzegorzewska AE; Mostowska A; Warchoł W; Jagodziński PP
BMC Infect Dis; 2021 Aug; 21(1):875. PubMed ID: 34445971
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Thymine--Adenine Dinucleotide Repeat, IL28B and IFNL4 in Thai Population and Correlation with Spontaneous Clearance and Treatment Outcome of Hepatitis C Infection.
Thong VD; Wasitthankasem R; Tangkijvanich P; Vongpunsawad S; Poovorawan Y
PLoS One; 2015; 10(5):e0125400. PubMed ID: 25938236
[TBL] [Abstract][Full Text] [Related]
9. Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4.
Bhushan A; Chinnaswamy S
Gene; 2018 Jul; 664():168-180. PubMed ID: 29705128
[TBL] [Abstract][Full Text] [Related]
10. Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses.
Grzegorzewska AE
Curr Med Chem; 2019; 26(25):4832-4851. PubMed ID: 30027841
[TBL] [Abstract][Full Text] [Related]
11. Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3.
Rembeck K; Waldenström J; Hellstrand K; Nilsson S; Nyström K; Martner A; Lindh M; Norkrans G; Westin J; Pedersen C; Färkkilä M; Langeland N; Buhl MR; Mørch K; Christensen PB; Lagging M
Hepatology; 2014 Jun; 59(6):2131-9. PubMed ID: 24519039
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.
Stättermayer AF; Strassl R; Maieron A; Rutter K; Stauber R; Strasser M; Beinhardt S; Datz C; Scherzer TM; Steindl-Munda P; Gschwantler M; Trauner M; Hofer H; Ferenci P
Aliment Pharmacol Ther; 2014 Jan; 39(1):104-11. PubMed ID: 24205831
[TBL] [Abstract][Full Text] [Related]
13. IFN-λ4: the paradoxical new member of the interferon lambda family.
O'Brien TR; Prokunina-Olsson L; Donnelly RP
J Interferon Cytokine Res; 2014 Nov; 34(11):829-38. PubMed ID: 24786669
[TBL] [Abstract][Full Text] [Related]
14. Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects.
Onabajo OO; Wang F; Lee MH; Florez-Vargas O; Obajemu A; Tanikawa C; Vargas JM; Liao SF; Song C; Huang YH; Shen CY; Banday AR; O'Brien TR; Hu Z; Matsuda K; Prokunina-Olsson L
Front Immunol; 2021; 12():692263. PubMed ID: 34497603
[No Abstract] [Full Text] [Related]
15. Inosine Triphosphate Pyrophosphatase Dephosphorylates Ribavirin Triphosphate and Reduced Enzymatic Activity Potentiates Mutagenesis in Hepatitis C Virus.
Nyström K; Wanrooij PH; Waldenström J; Adamek L; Brunet S; Said J; Nilsson S; Wind-Rotolo M; Hellstrand K; Norder H; Tang KW; Lagging M
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045981
[TBL] [Abstract][Full Text] [Related]
16. Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.
Thompson AJ; Santoro R; Piazzolla V; Clark PJ; Naggie S; Tillmann HL; Patel K; Muir AJ; Shianna KV; Mottola L; Petruzzellis D; Romano M; Sogari F; Facciorusso D; Goldstein DB; McHutchison JG; Mangia A
Hepatology; 2011 Feb; 53(2):389-95. PubMed ID: 21274861
[TBL] [Abstract][Full Text] [Related]
17. Cellular Mechanism for Impaired Hepatitis C Virus Clearance by Interferon Associated with IFNL3 Gene Polymorphisms Relates to Intrahepatic Interferon-λ Expression.
Ferraris P; Chandra PK; Panigrahi R; Aboulnasr F; Chava S; Kurt R; Pawlotsky JM; Wilkens L; Osterlund P; Hartmann R; Balart LA; Wu T; Dash S
Am J Pathol; 2016 Apr; 186(4):938-51. PubMed ID: 26896692
[TBL] [Abstract][Full Text] [Related]
18. What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?
O'Brien TR; Jackson SS
J Interferon Cytokine Res; 2019 Oct; 39(10):618-626. PubMed ID: 31161939
[TBL] [Abstract][Full Text] [Related]
19. Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant.
Konishi H; Motomura T; Matsumoto Y; Harimoto N; Ikegami T; Yoshizumi T; Soejima Y; Shirabe K; Fukuhara T; Maehara Y
J Viral Hepat; 2014 Jun; 21(6):397-404. PubMed ID: 24750545
[TBL] [Abstract][Full Text] [Related]
20.
Baker FS; Wang J; Florez-Vargas O; Brand NR; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Chagaluka G; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Prokunina-Olsson L; Mbulaiteye SM
J Interferon Cytokine Res; 2023 Sep; 43(9):394-402. PubMed ID: 37366802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]